- The Justice Department's decision to drop a criminal case against Abbott Laboratories over contaminated baby formula has led to a broader pullback on prosecuting companies in the consumer health sector.
- Internal changes, including a 2025 reorganization and heightened evidentiary standards, have delayed or stalled other investigations, with prosecutors now requiring stronger evidence before bringing charges.
- Despite DOJ claims of continued enforcement, the closure of high-profile cases like Abbott's has raised concerns among former officials about the administration's commitment to consumer protection.